The evolution of assays for immuno-oncology research
Drug Discovery World
FEBRUARY 15, 2023
Genetically engineered mouse models (GEMM) recapitulate the stromal biology of different human cancers including the tumour microenvironment that regulates the disease process. Reagents that can augment and enhance ADCC are of interest in addition to the antibodies themselves. EMBO Mol Med 2017;9:137–53.doi:10.15252/emmm.201606857pmid:[link]
52 
Let's personalize your content